Patents by Inventor Cornelia Hampe

Cornelia Hampe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric Polypeptides Useful in Proximal and Dynamic High-Throughput Screening Methods
    Publication number: 20130035256
    Abstract: The present invention provides a method of high-throughput screening (HTS) of active agents of a cell-surface G-Protein coupled receptor (GPCR) or another target receptor of interest. The method uses a non-invasive, sensitive reporting system that is proximal to the target of interest, combined with a dynamic, automated screening procedure so as to detect orthosteric ligands, such as agonists and antagonists, but is also suitable to detect allosteric or low affinity active agents of a GPCR and possibly other disease-related receptors.
    Type: Application
    Filed: April 20, 2011
    Publication date: February 7, 2013
    Applicant: ADDEX PHARMA SA
    Inventors: Tina Gjoni, Dominik Schelshorn, Cornelia Hampe, Aurelie Gouiller, Robert Lutjens
  • Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
    Patent number: 7070940
    Abstract: The present invention relates to a method for determining the ability of a compound to modify the interaction between parkin and the p38 protein, and in particular to a method for screening for or detecting compounds intended for the prevention and/or treatment of neurodegenerative pathological conditions. The present inventions also relates to compounds identified in the above screening method.
    Type: Grant
    Filed: July 18, 2003
    Date of Patent: July 4, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Olga Corti, Cornelia Hampe, Alexis Brice, Laurent Pradier, Thomas Rooney, Alain Fournier
  • Method for determining the ability of a compound to modify the interaction between parkin and the p38 protein
    Publication number: 20040214763
    Abstract: The present invention relates to a method for determining the ability of a compound to modify the interaction between parkin and the p38 protein, and in particular to a method for screening for or detecting compounds intended for the prevention and/or treatment of neurodegenerative pathological conditions.
    Type: Application
    Filed: July 18, 2003
    Publication date: October 28, 2004
    Applicants: Aventis Pharma, S.A., L'Institue Nat'l Santa Recherche Medicale
    Inventors: Olga Corti, Cornelia Hampe, Alexis Brice, Laurent Pradier, Thomas Rooney, Alain Fournier